Brussels has decided that this is the time when Britain’s biotech and pharmaceutical companies might be enticed into moving to Europe’s capital.
Following the British Parliament’s rejection an agreed plan for withdrawal from the European Union, UK legislators have also rejected leaving the Union without any agreement. What this means is that Parliament will continue to muddle on. No one knows for how long or whether the Europe will put up with another lengthy dither.